HIIFS
ADMA icon

Harel Insurance Investments & Financial Services’s ADMA Biologics ADMA Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,000
Closed -$7K – 451
2018
Q4 		$7K Hold
3,000
– – ﹤0.01% 415
2018
Q3 		$19K Buy
+3,000
New +$17.3K ﹤0.01% 427

Other funds holding ADMA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
MWVC
Morgens Waterfall Vintiadis & Co New York $81.2M AUM 86.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Harel Insurance Investments & Financial Services's ADMA Position: Q1 2019 in Review

Harel Insurance Investments & Financial Services sold out of ADMA Biologics (ADMA) in Q1 2019, closing a stake of 3,000 shares — an estimated $7K sold.

Harel Insurance Investments & Financial Services first reported a position in ADMA in Q3 2018 and held it in 2 quarters. The position peaked at $19K in Q3 2018. 56 funds tracked by Wall St. Rank hold ADMA as of Q1 2019.

  • Harel Insurance Investments & Financial Services reported no remaining ADMA Biologics position as of Q1 2019 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 3,000 ADMA Biologics shares in Q1 2019, an estimated $7K.
  • Harel Insurance Investments & Financial Services first reported a position in ADMA Biologics in Q3 2018 and held it in 2 quarters.
  • Harel Insurance Investments & Financial Services's ADMA Biologics position peaked at $19K in Q3 2018.
  • 56 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2019.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2019, filed 18 Apr 2019.